|
Index of reports
> Cases with Malaise (88)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include malaise. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 88 Next >>
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Productive Cough, Contusion, Bone Pain, Chills, Flatulence, Hepatic Lesion, Neoplasm Progression, Constipation, Fall, Faeces Discoloured, Malaise, Road Traffic Accident, Depression, Cough, Ligament Sprain, Defaecation Urgency, Blood Pressure Systolic Increased, Pain in Extremity, Breast Neoplasm, Diarrhoea, Alopecia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Indication: Carcinoid Tumour
Start date: 2009-06-01
Sandostatin
Dosage: 50 ug, unk
Indication: Carcinoid Tumour
Start date: 2009-05-21
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Tremor, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Feeling Jittery, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: male
Reactions: Jaundice, Abdominal Pain, Blood Bilirubin Increased, Confusional State, Agitation, Weight Decreased, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Malaise, Fatigue, Pleural Effusion, Cardiac Failure Congestive, Cough, Decreased Appetite, Lethargy, Blood Pressure Increased, Dyspnoea, Restlessness, Pain in Extremity, Ascites, Discomfort, Heart Rate Decreased, Abdominal Mass, Syncope, Micturition Disorder, Joint Swelling, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Other drugs received by patient: Sutent
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-08-16
Patient: female
Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Thermal Burn, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Gastrinoma
Start date: 2010-06-21
Sandostatin
Dosage: 50 ug, unk
Indication: Gastrinoma
Start date: 2010-06-10
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, qmo
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-10
Patient: male
Reactions: Haemorrhage, Hypotension, Tachycardia, Malaise, Postoperative Wound Infection, Pleural Effusion, Bone Disorder, Septic Shock, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, once a month
Indication: Haemorrhage
Start date: 2012-06-20
Sandostatin
Dosage: 150 ug, tid
Indication: Haemorrhage
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-07
Patient: male
Reactions: Tachycardia, Hypotension, Wound Secretion, Occult Blood Positive, Malaise, Pulmonary Oedema, Bone Disorder, Septic Shock, Asthenia, TOE Amputation, Post Procedural Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 150 ug, tid
Indication: Haemorrhage
Sandostatin LAR
Dosage: 30 mg, once a month
Indication: Haemorrhage
Start date: 2012-06-20
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-06
Patient: male
Reactions: Blood Bilirubin Increased, Confusional State, Weight Decreased, Abdominal Pain, Agitation, Jaundice, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Fatigue, Malaise, Pleural Effusion, Cough, Decreased Appetite, Lethargy, Cardiac Failure Congestive, Blood Pressure Increased, Dyspnoea, Pain in Extremity, Restlessness, Discomfort, Ascites, Syncope, Abdominal Mass, Heart Rate Decreased, Joint Swelling, Micturition Disorder, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Other drugs received by patient: Sutent
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-08-01
Patient: female
Reactions: Haemorrhage, Rectal Haemorrhage, Malaise, Fatigue, White Blood Cell Count Increased, Lethargy, Vomiting, Loss of Control of Legs, Nausea, Urinary Tract Infection, Injection Site Pain, Facial Pain, Blood Creatine Increased, Tremor, Discomfort, Haemoglobin Decreased, Diarrhoea, Liver Abscess, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Tumour
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2011-07-05
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Carcinoid Tumour
Start date: 2011-07-05
Other drugs received by patient: Norfloxacin
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-25
Patient: female
Reactions: Productive Cough, Contusion, Flatulence, Chills, Bone Pain, Hepatic Lesion, Neoplasm Progression, Constipation, Fall, Faeces Discoloured, Road Traffic Accident, Malaise, Depression, Ligament Sprain, Cough, Defaecation Urgency, Pain in Extremity, Blood Pressure Systolic Increased, Breast Neoplasm, Diarrhoea, Alopecia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Indication: Carcinoid Tumour
Start date: 2009-06-01
Sandostatin
Dosage: 50 ug, unk
Indication: Carcinoid Tumour
Start date: 2009-05-21
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-07-25
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Confusional State, Weight Decreased, Incorrect Route of Drug Administration, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Discomfort, Injection Site Erythema, Malaise, Fatigue, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 0.75 ml, tid prn
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-07-24
Patient: male
Reactions: Postoperative Wound Infection, Malaise, Haemorrhage, Tachycardia, Hypotension, Bone Disorder, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 20 mg, qmo
Start date: 2012-06-20
Sandostatin
Dosage: 150 ug, tid
Indication: Haemorrhage
Sandostatin
Dosage: 30 mg, qmo
Start date: 2012-06-20
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-20
Patient: female
Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Asthenia, Thermal Burn, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Gastrinoma
Start date: 2010-06-10
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Gastrinoma
Start date: 2010-06-21
Sandostatin LAR
Dosage: 20 mg, qmo
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Dizziness, Abdominal Distension, Anuria, Blood Pressure Increased, Back Pain, Humerus Fracture, Gastrointestinal Motility Disorder, Vomiting, Pain in Extremity, Nausea, Flushing, Arthralgia, Diarrhoea, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-04
Patient: female
Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: female
Reactions: Malaise, Vomiting, Nausea, Dyspepsia, Haemorrhoids, Constipation, Anal Fissure
Drug(s) suspected as cause:
Citrate Magnesia
Dosage: unk
Sandostatin
Dosage: unk
Somavert
Dosage: unk
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-26
Patient: female
Reactions: Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Possible Sandostatin side effects in female
Reported by a physician from Australia on 2012-06-25
Patient: female
Reactions: Malaise, Drug Ineffective, Breast Mass, Infection
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, every three weeks
Indication: Acromegaly
Start date: 2012-05-14
Sandostatin
Dosage: 0.05 mg, as when required
Start date: 2012-05-29
Sandostatin
Dosage: 0.05 mg, as when required
Indication: Acromegaly
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-25
Patient: female
Reactions: Blood Pressure Increased, Poor Quality Sleep, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Thermal Burn, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Gastrinoma
Start date: 2010-06-10
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Gastrinoma
Start date: 2010-06-21
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, qmo
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-06
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Erythema, Fatigue, Injection Site Discomfort, Malaise, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Blood Pressure Systolic Increased, Pain in Extremity, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Possible Sandostatin side effects in female
Reported by a physician from Australia on 2012-06-04
Patient: female
Reactions: Malaise, Drug Ineffective, Breast Mass, Infection
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, every three weeks
Start date: 2012-05-14
Sandostatin
Dosage: 0.05 mg, as when required
Indication: Acromegaly
Sandostatin LAR
Dosage: 20 mg, unk
Indication: Acromegaly
Sandostatin
Dosage: 0.05 mg, as when required
Start date: 2012-05-29
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-30
Patient: female
Reactions: Nasopharyngitis, Flatulence, Neoplasm Progression, Synovial Cyst, Fatigue, Malaise, Oedema Peripheral, Proctalgia, Cough, Viral Infection, Nausea, Abnormal Faeces, Faecal Incontinence, Diarrhoea, Joint Swelling, Influenza Like Illness
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-25
Sandostatin
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-22
Other drugs received by patient: Other Anti-Asthmatics, Inhalants
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-05-28
Patient: male
Reactions: Pneumonia, Nasopharyngitis, Neoplasm Progression, Blood Calcium Increased, Pulmonary Embolism, Malaise, Blood Phosphorus Decreased, Neoplasm Malignant, Heart Rate Increased, Dehydration, Carbon Dioxide Increased, Anion GAP Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 10 mg,
Administration route: Oral
Indication: Thymic Cancer Metastatic
Start date: 2010-12-06
Zometa
Dosage: 4 mg every 3 weeks
Indication: Thymic Cancer Metastatic
Start date: 2010-05-26
End date: 2012-04-27
Aredia
Indication: Thymic Cancer Metastatic
Sandostatin
Dosage: 30 mg, once in 4 weeks
Indication: Thymic Cancer Metastatic
Start date: 2008-12-27
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-28
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Fatigue, Injection Site Discomfort, Injection Site Erythema, Malaise, Hot Flush, Oedema Peripheral, Abdominal Distension, Dizziness, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 0.75 ml, bid
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-28
Patient: female
Reactions: Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Malaise, Fatigue, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-25
Patient: female
Reactions: Back Pain, Blood Pressure Increased, Abdominal Pain, Renal Disorder, Pain, Breakthrough Pain, Injection Site Pain, Laceration, Neoplasm Progression, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every four weeks
End date: 2012-02-22
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-20
End date: 2011-01-23
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-24
Other drugs received by patient: Fentanyl-100; Dexamethasone; Dilaudid
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-25
Patient: female
Reactions: Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-24
Patient: female
Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Asthenia, Thermal Burn, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin
Dosage: 50 ug, unk
Indication: Gastrinoma
Start date: 2010-06-10
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Gastrinoma
Start date: 2010-06-21
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-23
Patient: male
Reactions: Nasopharyngitis, Pneumonia, Blood Calcium Increased, Pulmonary Embolism, Blood Phosphorus Decreased, Malaise, Heart Rate Increased, Dehydration, Carbon Dioxide Increased, Anion GAP Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zometa
Dosage: 4 mg every 3 weeks
Indication: Thymic Cancer Metastatic
Start date: 2010-05-26
Aredia
Indication: Thymic Cancer Metastatic
Sandostatin
Dosage: 30 mg, once in 4 weeks
Indication: Thymic Cancer Metastatic
Start date: 2008-12-24
Afinitor
Dosage: 10 mg,
Administration route: Oral
Indication: Thymic Cancer Metastatic
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-22
Patient: female
Reactions: Blood Pressure Increased, Back Pain, Abdominal Pain, Renal Disorder, Pain, Injection Site Pain, Laceration, Breakthrough Pain, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-24
Sandostatin
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-20
End date: 2011-01-23
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 20 mg, every four weeks
Other drugs received by patient: Dexamethasone; Dilaudid; Fentanyl-100
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-22
Patient: female
Reactions: Nasopharyngitis, Flatulence, Neoplasm Progression, Synovial Cyst, Malaise, Fatigue, Oedema Peripheral, Cough, Proctalgia, Viral Infection, Nausea, Abnormal Faeces, Faecal Incontinence, Diarrhoea, Joint Swelling, Influenza Like Illness
Drug(s) suspected as cause:
Sandostatin
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-25
Other drugs received by patient: Other Anti-Asthmatics, Inhalants
Page 1 Next >>
|
